Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Cancer Research
|
September 5, 2006
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice
Nicole M Sodir, Xuan Chen, Ryan Park, et al.
The Journal of Laboratory and Clinical Medicine
|
October 1, 1984
Renal ischemic injury in the dog: characterization and effect of various pharmacologic agents
R M Lewis, J H Rice, M K Patton, et al.
Cancer Biology & Therapy
|
April 15, 2015
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
Maria R Abbattista, Stephen M F Jamieson, Yongchuan Gu, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
September 8, 2005
[New pathways in undergraduate medical education - first experiences with the cross section speciality emergency and intensive care medicine]
A Timmermann, M Roessler, J Barwing, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Navigating the Blood-Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
Lucas E L Terceiro, Nnamdi M Ikeogu, Matheus F Lima, et al.
Cardiovascular Research
|
November 13, 2004
Inhibition of TGFbeta signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis
Farah Sheikh, Cheryl J A Hirst, Yan Jin, et al.
Der Anaesthesist
|
November 2, 2006
[Teaching and simulation. Methods, demands, evaluation and visions]
A Timmermann, C Eich, S G Russo, et al.
Plos One
|
May 16, 2014
High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling
Jon-Jon Santiago, Leslie J McNaughton, Navid Koleini, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 10, 2018
Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity
Navid Koleini, Jon-Jon Santiago, Barbara E Nickel, et al.
Cell and Tissue Research
|
May 31, 2021
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression
Navid Koleini, Barbara E Nickel, Raghu S Nagalingam, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Cancer Research
|
September 5, 2006
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice
Nicole M Sodir, Xuan Chen, Ryan Park, et al.
The Journal of Laboratory and Clinical Medicine
|
October 1, 1984
Renal ischemic injury in the dog: characterization and effect of various pharmacologic agents
R M Lewis, J H Rice, M K Patton, et al.
Cancer Biology & Therapy
|
April 15, 2015
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
Maria R Abbattista, Stephen M F Jamieson, Yongchuan Gu, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
September 8, 2005
[New pathways in undergraduate medical education - first experiences with the cross section speciality emergency and intensive care medicine]
A Timmermann, M Roessler, J Barwing, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Navigating the Blood-Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
Lucas E L Terceiro, Nnamdi M Ikeogu, Matheus F Lima, et al.
Cardiovascular Research
|
November 13, 2004
Inhibition of TGFbeta signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis
Farah Sheikh, Cheryl J A Hirst, Yan Jin, et al.
Der Anaesthesist
|
November 2, 2006
[Teaching and simulation. Methods, demands, evaluation and visions]
A Timmermann, C Eich, S G Russo, et al.
Plos One
|
May 16, 2014
High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling
Jon-Jon Santiago, Leslie J McNaughton, Navid Koleini, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 10, 2018
Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity
Navid Koleini, Jon-Jon Santiago, Barbara E Nickel, et al.
Cell and Tissue Research
|
May 31, 2021
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression
Navid Koleini, Barbara E Nickel, Raghu S Nagalingam, et al.
Page
of 10